Active, Not Recruiting
Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
NCT05722327
- Conditions
- Colon Cancer, Colonic Diseases, Colonic Neoplasms, +11 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States